<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04198298</url>
  </required_header>
  <id_info>
    <org_study_id>20-60</org_study_id>
    <nct_id>NCT04198298</nct_id>
  </id_info>
  <brief_title>Prospective Clinical Trial of Three Apical Sealing Materials</brief_title>
  <official_title>Prospective Comparative Randomized Clinical Trial of Three Endodontic Retrograde Filling Materials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of the Pacific</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of the Pacific</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective comparative randomized clinical trial compares healing and bony regeneration
      in patients who received 1 of 3 different retrograde filling materials following
      microsurgical apicoectomies for the treatment of periapical lesions of endodontic origin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective comparative randomized clinical trial was designed to evaluate the healing and
      bony regeneration in patients who received 1 of 3 different retrograde filling materials
      (EndoSequence®, ProRoot® MTA, or Biodentine®) following microsurgical apicoectomies for the
      treatment of periapical lesions of endodontic origin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2, 2014</start_date>
  <completion_date type="Actual">May 31, 2017</completion_date>
  <primary_completion_date type="Actual">May 31, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of remineralization</measure>
    <time_frame>6 months</time_frame>
    <description>The pace at which new bone is redeposited</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Periapical Abscess</condition>
  <arm_group>
    <arm_group_label>Group 1 EndoSequence</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 ProRoot MTA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 Biodentine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EndoSequence</intervention_name>
    <description>The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.</description>
    <arm_group_label>Group 1 EndoSequence</arm_group_label>
    <other_name>EndoSequence®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ProRoot MTA</intervention_name>
    <description>The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.</description>
    <arm_group_label>Group 2 ProRoot MTA</arm_group_label>
    <other_name>ProRoot® MTA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Biodentine</intervention_name>
    <description>The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.</description>
    <arm_group_label>Group 3 Biodentine</arm_group_label>
    <other_name>Biodentine®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients, American Society of Anesthesiologists (ASA) classification I and II

          -  Any tooth with a single chronic periapical lesion requiring apical microsurgery

          -  Informed consent signed prior to surgery

        Exclusion Criteria:

          -  Background of drug/alcohol abuse

          -  Adjacent periapical lesion

          -  Periodontal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>December 12, 2019</last_update_submitted>
  <last_update_submitted_qc>December 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cone-Beam Computed Tomography</keyword>
  <keyword>Microsurgery</keyword>
  <keyword>Bone Regeneration</keyword>
  <keyword>Biocompatible Materials</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periapical Abscess</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

